Fundraising FoxUnixell
1 known investors
Find your way into Unixell
Sign up to see every warm intro you have to Unixell
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Unixell team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Unixell Biotech develops advanced cell therapy platforms including reprogramming, stem cell differentiation, lineage tracing, and gene editing technologies to create neural cell therapeutics for clinical applications. The company's lead program is UX-DA001, a midbrain dopamine precursor cell therapy for Parkinson's disease, which has received clinical trial approval from Chinese and US regulatory authorities.
Investors · 1
In the news
Frequently asked questions
- What does Unixell do?
- Unixell Biotech develops advanced cell therapy platforms including reprogramming, stem cell differentiation, lineage tracing, and gene editing technologies to create neural cell therapeutics for clinical applications. The company's lead program is UX-DA001, a midbrain dopamine precursor cell therapy for Parkinson's disease, which has received clinical trial approval from Chinese and US regulatory authorities.
- Who are Unixell's investors?
- Unixell's investors include Pan-Lin Capital.